Buys
Open market- Shares
- +14,000
- Avg price
- $15.53
- Total value
- +$217,420
Steve Elms - Director at ADMA BIOLOGICS, INC.
Issuer-level insider activity
- Role
- Director
- Issuer ticker
- ADMA on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
Past-year transaction volume for Steve Elms in ADMA BIOLOGICS, INC.
Sells
Open market- Shares
- Avg price
- Total value
Net
Past year- Shares
- +14,000
- Share %
- 100%
- Total value
- +$217,420
Reported holdings for Steve Elms in ADMA BIOLOGICS, INC.
Form 4 holding
Director
ADMA BIOLOGICS, INC.
- Security class
- Common Stock
- Shares / value
- 2,045,730
- Estimated value
- $31,483,784
- Report date
- 06 Mar 2026
- Price
- $15.39
- Ownership
- Indirect
Form 4 holding
Director
ADMA BIOLOGICS, INC.
- Security class
- Common Stock
- Shares / value
- 98,020
- Estimated value
- $1,595,765
- Report date
- 05 Mar 2026
- Price
- $16.28
- Ownership
- Direct
Form 4 holding
Director
ADMA BIOLOGICS, INC.
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 17,730
- Estimated value
- $59,581
- Report date
- 09 Feb 2026
- Price
- $3.66
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Steve Elms in ADMA BIOLOGICS, INC.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.